Background {#Sec1}
==========

The main goals of nutritional management of patients in end stage kidney disease (ESKD) are to maintain optimal nutrition status and prevent complications associated with deteriorating renal function, such as high blood pressure, malnutrition, symptom burden, electrolytes/fluid imbalances, and increased cardiovascular risk. The additional specific goals for non-dialysis CKD stages 4--5 patients are to (1) preserve renal function and delay disease progression, (2) delay onset of uraemic symptoms, (3) have a healthy start of dialysis, and improve the quality of life of patients, especially if they are on a conservative pathway. From the author's personal experience, referrals by nephrologists to dietitians for non-dialysis CKD nutrition intervention have dropped significantly since the release of the Modification of Diet in Renal Disease (MDRD) \[[@CR1]\] study in 1994 as the initial results did not show a significant reduction in the rate of renal disease progression. To date, referral remains ad hoc depending on the subjective belief of the nephrologists, despite the supportive evidence available in the literature \[[@CR2]--[@CR4]\], MDRD follow-up study \[[@CR5]\], Cochrane systematic review \[[@CR6]\], and renal nutrition practice guidelines, e.g. Kidney Disease Outcome Quality Initiative (KDOQI)D \[[@CR7]\] and Dietitians Association of Australia (DAA) \[[@CR8]\]. This has been a common phenomenon in the renal community in Australia for many years. It was highlighted in a recent national survey of nutrition practice in stages 4--5 non-dialysis CKD that showed approximately 17 % and 46 % of renal dietitians perceived their nephrologists/renal team as "very supportive' or "somewhat supportive" respectively of the use of low protein diets \[[@CR9]\]. The majority of respondents (34.2 %) reported less than 10 % of patients received structured nutrition intervention before starting dialysis in their centres. However, referral for dietary management to optimise blood pressure, body weight/energy balance, fluid, serum potassium, and phosphate imbalances could be more regular. Furthermore, due to an exponential increase in dialysis patients over the last two decades and inadequate renal dietitian staffing, services have been shifted to focus on patients on dialysis and transplantation programs instead. In coming years, the role of nutrition intervention in non-dialysis CKD could become important again, as there is ample evidence suggesting pre-dialysis nutrition factors are associated with dialysis outcomes \[[@CR10], [@CR11]\], as well as a growing trend for supporting patients on conservative care pathways \[[@CR12], [@CR13]\].

Research leading to current practices {#Sec2}
-------------------------------------

As recommended by the KDOQI and DAA guidelines for haemodialysis patients, all hospital and satellite centre patients receive six-monthly nutrition reviews. Prevalence of malnutrition as rated by subjective global assessment (SGA) was consistently high at 40-50 % in reviews performed in the early 2000s, and many of these patients were new on the dialysis program. Further study indicated that less than 30 % of new patients received nutrition intervention in pre-dialysis stages. Together with education needs for other disciplines, a multidisciplinary pre-dialysis assessment clinic was established to provide timely management for patients on a pre-dialysis pathway. Nephrologists refer patients with GFR \<30 mL/min to this renal specialty clinic for assessment and education by the clinical nurse consultant, social worker, pharmacist, and a dietitian in a session lastings approximately 3 h. Patients and caretakers are informed about "Renal Options" or different treatment choices such as haemodialysis, continuous ambulatory peritoneal dialysis (CAPD) verse automated peritoneal dialysis (APD), conservative care and transplantation, whereas the social worker assessed their psycho-social status and needs \[[@CR14]\]. The renal dietitian became responsible for the nutrition assessment (Table [1](#Tab1){ref-type="table"}) and intervention under "blanket referral" based on clinical practice guidelines and agreed department protocols. This means, by protocols, there is no screening or triaging by the nurse consultant, and all patients are assessed by the dietitian. After the initial assessment, patients are informed of their results and receive brief education on the role of dietary management in CKD, in particular, the concept of how nutrition intervention helps to preserve renal function, reduce complications, maintain better nutritional status, and to aim for a healthy start of dialysis. In general, patients are advised to attend ongoing counselling and intervention sessions in the Nutrition and Dietetics Department until dialysis starts. If patients wish to make a decision regarding the uptake of intervention, they are advised to contact the detitians when ready or the nephrologist to re-refer, if any nutritional issues arise. In addition, nephrologists also refer other non-dialysis CKD stages 3b-5, including conservative care patients directly to renal dietitians for nutrition counselling. As part of the clinical practice improvement process, the roles of nutrition intervention and practices were revisited in the non-dialysis CKD group in our centre, addressing the question, "Is nutrition management good enough only when it starts at or near dialysis initiation?"Table 1Nutrition management protocols of CKD Stages 4--5 (non- dialysed)Dietary Protocol: In GeneralAs per clinical practice guidelines and a balanced dietProteinApproximately 0.75-1.0 g /kg IBW/d (Australian RDI)\
Approximately 70 % HBV protein\
Remark:\
▪ \~0.6 g/kg IBW/d (and no less) for patients with severe symptoms (usually applicable to patients in advance stage of conservative care)\
▪ For nutrition support or repletion \~ 1.0 g /kg IBW/d\
▪ A high protein diet for nutrition support in malnourished patients, or weight reduction in overweight/obese patients is inappropriateEnergyAim to attain and maintain IBW\
Depending on physical activity level\
35--45 Kcal (150-190KJ)/kg IBW/d for \<60 years\
30--35 Kcal (130-150KJ)/kg IBW/d for \>60 years\
▪ energy from CHO approximately 50-60 %\
▪ energy from Fat approximately 30-35 %.\
Adapted to individual needs in the case of under-nutrition or overweight/obesitySodiumIf hypertension or oedema present:\
Approximately 80 mmol/d (no added salt)\
▪ May need lower sodium intake if severe oedema present, e.g. 50 mmol/d\
▪ May need higher sodium intake in patients with salt-losing nephropathyPotassiumNo restriction unless hyperkalaemia present\
40-70 mmol/d if restriction requiredPhosphorus\<1000 mg/d if hyperphosphatemia present + phosphate bindersFat▪ Encouraged Mono- and poly-unsaturated fats\
▪ Saturated fat \<10 % of energy\
▪ Cholesterol \<300 mg/dAlcoholNo more than 2 standard drinks per day or advised by renal physicianVitamins &\
Minerals (diet)Near RDI levelsVitamins &\
Minerals\
(supplementation)May need individualised calcium, iron and vitamin D supplementation. May need supplementation of Vitamin B complex, Vitamin C and folate acid near RDI levels if protein intake is \<60 g/dayFluidUO + 500 ml/d, depending on balanceDietary PatternRegular inclusion of fruit and vegetables, and dietary fibreRecommended intervention (outpatient, minimum)Initial appointment \~ 2 h, then review every 1--3 months, and more frequently if clinically indicated. Then 6 monthly in stable patients (minimum 6 h per annum).\
• Stable CKD and pre-dialysis patients:\
 ▪ Follow up until dialysis commences\
• Conservative pathway:\
 ▪ Follow up until withdrawing from treatment or for end of life careModified from the "Nutrition Protocols for the Management of People with Kidney Disease, The St. George Hospital, Sydney \[[@CR17]\]. Abbreviations: IBW, ideal body weight; RDI, recommended daily intake; HBV, high biological value

In a ten-year clinical cohort study of patients who commenced planned dialysis programs, the prevalence of malnutrition as scored by SGA B & C was found to be approximately 52 %. Multivariate analysis indicated malnutrition was an independent predictor of mortality, irrespective of the glomerular filtration rate (eGFR) at which dialysis started; and high body mass index (BMI) values did not show any protective effects \[[@CR11]\]. In addition, the combination of malnutrition (SGA B & C) and overweight/obesity (BMI ≥ 26 kg/m^2^) was associated with the worse outcomes. From experience, nutritional status improves in most patients after starting dialysis; unfortunately the moderate to severely malnourished patients often showed sub-optimal improvement despite intense nutritional support. In the study of nutritional characteristics of patients attending the pre-dialysis clinic, mean eGFR was 17.3 ± 6.5 mL/min/1.73 m^2^ and 40.5 % of patients were rated as malnourished. Indeed, nutrition abnormalities merge well before dialysis is needed \[[@CR15]\]. Factors associated with abnormal nutrition parameters included declining eGFR, symptom burden causing poor intake, poor habitual eating habits, and inappropriate intake due to lack of nutrition knowledge in managing CKD. "Is nutrition management good enough only when it starts at or near dialysis initiation?" The answer is no. The results of these studies suggested structured nutrition management should be implemented well before dialysis is required, and even before the pre-dialysis stage to improve health outcomes, as well as potential healthcare cost savings. Furthermore, not all ESKD patients benefit from dialysis, therefore timely nutrition intervention is vital to preserve renal function and maintain quality of life in patients choosing conservative care.

Current practices {#Sec3}
-----------------

In our centre, renal dietitians receive referrals from nephrologists, either directly or through "blanket referral" in the multidisciplinary pre-dialysis assessment and renal supportive care clinics. Patients receive intervention within the framework of the nutrition care process (NCP), namely structured care including assessment, diagnosis, intervention, and monitoring/evaluation \[[@CR16]\]; as well as dietary prescription and frequency and duration of intervention as recommended by the clinical and work practice guidelines summarised into the agreed local protocols \[[@CR17]\]. Table [1](#Tab1){ref-type="table"} summaries the nutrition management protocols for CKD (non-dialysis) stage 4--5. These protocols are regularly updated with agreements sought from the renal team during the review process.

"Low protein diet" has not been well accepted by the Australian nephrology community, as there is no high-level evidence to support such practice. Many clinicians perceive a "low protein diet" or "restricted protein diet" as restrictive and leading to treatment burden and malnutrition. With these beliefs, a "free diet" is often thought to help improve nutrition status and quality of life. Unfortunately, it doesn't guarantee appropriate and adequate intake, or good nutritional status. Problems can range from very poor spontaneous intake due to uraemia, or on the other hand, excessive habitual protein intake leads to uraemic toxin build-up and exacerbates symptoms \[[@CR18]\]. In addition, protein foods are naturally high in acids, purine, phosphorous and potassium. Therefore, uncontrolled protein food intake may also lead to other complications such as greater acid load, hyperuricaemia, hyperphosphatemia and hyperkalaemia. The national dietary survey reported that the habitual protein intake of the average Australian adult is almost twice the RDI level of 0.75 g/kg/d \[[@CR19]--[@CR21]\]. Patients often fail to recognise symptoms and the gradual reduction of food intake leads to deteriorating nutritional status. These nutritional problems surfaced during the period of decline in referral for nutrition intervention in non-dialysis CKD stages.

Uraemia is a word derived from two ancient Greek words, *ouron* (urine) and *haima* (blood), to describe the presence of increased urea and other nitrogenous end products of protein and amino acid metabolism in blood \[[@CR22], [@CR23]\]. Patients are in a chronic stage of protein intolerance or protein waste intoxication. To strike the balance between avoiding a build-up of nitrogenous waste and preventing protein energy wasting \[[@CR24]\], patients must consume the right amount of protein with adequate energy. However, the ideal level of protein intake for patients in stages 4--5 CKD is controversial \[[@CR25]\].

When energy intake is adequate, the physiological requirement of protein is approximately 0.6 g/kg ideal body weight (IBW)/d \[[@CR26], [@CR27]\]. The recommended daily intake (RDI) for adults in the general Australian population is approximately 0.75 g/kg/d (0.75 g/kg/d for women and 0.84 g/kg/d for men) \[[@CR27]\]. Clinically stable non-dialysed CKD patients have similar physiological requirements of \~0.6 g/kg IBW/d when energy ≥25 kcal/kg/d is ingested, and even more stable with 30--35 kcal/kg/d \[[@CR28]\], which are the recommended levels in clinical practice \[[@CR7]\]. In the elderly, protein RDI is approximately 1.0 g/kg/d \[[@CR27]\]. In view of these considerations, our patients are counselled on a "protein controlled diet" of 0.75-1.0 g/kg/d with adequate energy to attain or maintain ideal body weight. This practice is further supported by the results of a randomised controlled trial offering individualised nutrition counselling \[[@CR8]\] with a protein prescription of 0.75-1.0 g/kg/d, which showed significant improvements in nutritional status and symptom scores when compared to the control \[[@CR29]\]. Malnourished patients requiring nutrition support are advised \~1.0 g/kg IBW/d for repletion and anabolism; whereas stable conservatively managed patients with severe symptoms may require \~0.6 g/kg IBW/d and no less. To maintain good quality of life when patients are approaching end of life care, it is important to remind them about appropriate eating to alleviate symptoms and gain strength. Counselling will help them make informed decisions as to whether or not to follow any recommendations. High protein diets are not recommended for CKD patients, as they are associated with faster progression rate \[[@CR30], [@CR31]\]. Unfortunately, in recent years high protein diets for weight loss have become fashionable in the overweight/obese population, including CKD patients before they have a chance to learn about CKD nutrition.

The use of a very low protein diet, VLPD (0.3 g/kg/d plus keto-analogues of amino acids) in CKD patients is well studied and demonstrated favourable outcomes \[[@CR32]--[@CR34]\]. VLPD was trialled in Australia in the 1980s. Despite the favourable results of slowing down disease progression rate and symptom control, such treatment has never been adopted beyond the clinical trial stage. Currently, these products are not available in Australia and the VLPD regimens are not currently included in our nutrition management protocols Table [1](#Tab1){ref-type="table"}. Protein requirements and other nutrition considerations in CKD stages 1--3 have been reviewed and published recently \[[@CR35], [@CR36]\]. Again, protein intake near the RDI level is recommended. In summary, our nutrition management protocols adopt recommendations of our national \[[@CR8]\] and international \[[@CR7], [@CR33]\] guidelines.

Regular nutrition assessment, evaluation, and monitoring are vital to track patients' progress and outcomes. Table [2](#Tab2){ref-type="table"} shows the nutrition and clinical assessment checklist used, including the repeated measure in subsequent follow-up visit to monitor progress and diet adherence. It is important to focus on patient-centred outcomes; in addition to assessing the clinical parameters, patients and caretakers are encourage to inform dietitians of the enablers and barriers to better diet adherence.Table 2Nutrition and clinical assessment checklistNutritional assessmentDemographic(A) Anthropometry^a^AgeWeight and weight historyGenderHeightRaceBody Mass IndexSocial: occupation, living arrangementTriceps skinfoldClinical dataMid-Arm circumferenceCause of kidney failure(B) Biochemistry /blood results^a^Co-morbidities, presence of:Serum creatinine, eGFRCoronary artery diseaseSerum albumin, potassium, phosphate and C reactive protein, CRP (if available)\
HaemoglobinChronic lung disease(C) Clinical signs and symptoms^a^Cerebral vascular diseaseAppetite scorePeripheral vascular diseasePresence of nauseaDiabetes MellitusPresence of taste changeOther conditions affecting nutrition status e.g. cancer, liver disease etc.Presence of other symptoms (see section "O")Smoking habits(D) Dietary intake/ Drug^a^Future treatment optionDiet history (structured diet history method)Conservative careNutrient & food group analysesHaemodialysis(home/hospital)Drug (relevant medications e.g., phosphate binders etc. and drug- nutrient interaction)Peritoneal dialysis(E) Exercise and Physical activity^a^Transplantation(F) Functional status^a^Handgrip strengthDischarge from current program(O) Others^a^DateSubjective Global Assessment, SGA (7 point scale)Treatment modality or\
other reasonsPalliative care outcome scale (POS)eGFR and nutritional statusHow patients are feeling? Any question about the diet? Barrier and enabler to better diet adherence.Remark: recommended frequency and duration of intervention (1) initial assessment and education - 2 h (can be over 1--3 sessions depending on the patient's understand and skill to adhere to the diet, (2) then minimum 6 h per annum in established patients. Reference: in member only section of Dietitians Association of Australia, "Workforce recommendations for Renal dietitians in Australia and New Zealand" produced by the Australian and New Zealand renal dietitians workforce planning group, updated 2016^a^Repeat measure in subsequent follow-up visit to monitor progress

Beyond the protein-controlled diet in CKD {#Sec4}
-----------------------------------------

The risk affecting renal disease progression is multi-factorial and complex. In addition to traditional dietary modifications of energy and nutrients, e.g. protein, sodium, potassium, phosphorous, fluid, and fats \[[@CR37]\], there is growing evidence to address the benefits of other food components and dietary patterns for kidney health. These include the alkali-inducing effect of fruit and vegetable consumption in decreasing markers of kidney injury \[[@CR38]--[@CR41]\]. A high dietary fibre intake has been associated with reduced risk of inflammation and mortality in patients with CKD \[[@CR42], [@CR43]\] and the potential benefit of probiotics to decrease uremic toxin production \[[@CR44]--[@CR46]\]. Dietary patterns, such as a Mediterranean diet are associated with lower mortality risk in CKD \[[@CR47]\]; and a randomised control trail showed promising results in improving dyslipidaemia, markers of inflammation, and lipid peroxidation in stages 1--3 CKD patients \[[@CR48]\]. Campared to a Western dietary pattern, the Dietary Approach to Stop Hypertension (DASH)-style diet appeared to protect against rapid eGFR decline \[[@CR49]\]. In fact, many of these recommendations are in line with national dietary guideline for healthy eating for adults \[[@CR50], [@CR51]\]. Therefore, CKD diets actually encourage healthy food intake.

Practical issues {#Sec5}
----------------

Nutrition in CKD is a therapeutic intervention, as it is an integral part of medical care.

However, nutrition interventions are often seen as "lifestyle modifications", therefore clinicians and/or patients see them as low priority or optional treatments, especially when dietary modifications are mistakenly associated with restriction and treatment burden.

Renal dietitians counsel patients and caretakers according to the dietary prescription as detailed in Table [1](#Tab1){ref-type="table"}, and the information is tailor - made to suit their levels of comprehension and education. To improve adherence through coaching for better knowledge, skill and motivation, the main emphasis in the implementation steps are:Dietary practice▪ To tailor the diet plan.▪ To inform the quality and quantity of foods, and assist with pictures and drawings to reduce the burden of measurement or weighing.▪ To provide practical tips, e.g. shopping lists, recipes, etc.Build positive thinking mind-set▪ The diet should be practical and prescriptive, not restrictive.▪ The specific quality and quantity of foods recommended help to set realistic goals, so patients understand what and how much to eat.▪ The diet is similar to the recommendations for all Australians. It is a healthy diet for good health and the kidneys (i.e. no deprivation).▪ For the protein-controlled diet, eat enough protein, "not too much and not too little", as the kidneys have limited ability to remove waste, etc.▪ Symptomatic conservative care patients often experience "food phobia". A planned diet helps set realistic eating goals of knowing to eat adequately without exacerbating symptoms.▪ Provide essential information to help patients make informed decisions as to whether or not to follow the recommendations.Clear and realistic goal setting, especially around patient-centred outcomes

Challenges and strategies to achieve better outcomes {#Sec6}
----------------------------------------------------

A multi-disciplinary approach to nutrition management is vital to improve patient care \[[@CR52]\]. Together with healthcare professionals, patients and their caretakers are regarded as part of the renal team and are involved in decision-making and the planning of treatments.

There are many challenges to address. A change of diet is a change of habits; and patients' acceptance of change and intervention is vital, as is their willingness to attend clinics. One of the major complaints is not being able to attend too many medical appointments due to failing health or inconvenience. On the other hand, consistent with the literature \[[@CR53], [@CR54]\], many patients wish to include dietary guidance and intervention to prevent disease progression. Most importantly, common goals and a belief in nutrition therapy among the renal team allows timely structured intervention by the dietitians for delaying the need of and a healthier start of dialysis with a better 12 month survival \[[@CR55], [@CR56]\]. When the data of our centre is analysed, it will be interesting to compare results in different settings. The baseline nutritional status varied widely in our population \[[@CR15]\], ranging from underweight and malnourished to well-nourished with morbidly obese, as well as sarcopenic obesity. At this stage, through intervention, we have observed improvement of body weight, handgrip strength and SGA score in many malnourished patients, and gradual planned weight loss in overweight patients, as a result, a number of them required a lesser dose of antihypertensive medications. On the other hand, a small but significant number of patients declined or dropped out from nutrition intervention due to various reasons that are to be investigated. Examples are the burden to attend too many medical appointments, parking cost and a lack of understanding in the diet therapy etc. A detailed evaluation of all patients' progress and outcomes since the inception of this clinic is currently underway, the results will help gain more insight into the reality of nutrition intervention in such setting.

Regular communications, including patient meetings, reporting, quality audits, and ongoing research are importing strategies to improve care.

Conclusion {#Sec7}
==========

Optimal protein nutrition is part of the multifaceted nutritional therapy approach to managing patients with non-dialysis CKD, irrespective of the terminology used, i.e. "protein-controlled" versus "restricted protein" versus "low protein" diets. Appropriate protein prescription partners with adequate energy, other nutrients, food components and dietary patterns to form effective therapeutic interventions.
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